Service Agreement Amendment, dated April 6, 2022 by and between F-star Therapeutics Ltd and Neil Brewis, Ph.D

Contract Categories: Business Operations - Services Agreements
EX-10.3 4 fstx-ex10_3.htm EX-10.3 EX-10.3

Exhibit 10.3

 

 

 

 

 

 

 

STRICTLY PRIVATE & CONFIDENTIAL

Neil Brewis

Addresses

 

 

6 April 2022

 

 

 

 

Tel: +44 (0)1223 497400

Fax: +44 (0)1223 497461

***@***

 

F-star Therapeutics Limited Eddeva B920

Babraham Research Campus Cambridge

CB22 3AT

United Kingdom

www.f-star.com

 

 

 

Dear Neil

 

Amendment to Service Agreement

 

I am writing to confirm an Amendment to your Service Agreement with effect from 31 March 2022.

The parties hereby agree as follows:

1.
Section 18.6 of the Service Agreement is amended by deleting the reference to, “to the extent not assumed by an acquirer”.

 

2.
Except as specifically modified herein, any of the other terms of the Agreement shall remain in full force and effect.

 

 

In witness whereof, the parties hereto have executed the Amendment as of the date first written above.

 

 

 

For F-star Therapeutics Ltd

 

For Employee

Signature:

/s/ Eliot R. Forster

 

Signature:

/s/ Neil Brewis

Name:

Eliot Forster

 

Name:

Neil Brewis

Title:

Chief Executive Officer

 

Title:

Chief Scientific Officer

 

 

 

 

 

 

F-star Therapeutics Limited

Eddeva B920 | Babraham Research Campus | Cambridge, CB22 3AT, UK | T: +44 1223 497400 | www.f-star.com